Global Radiopharmaceuticals Market 2024-2028

Global Radiopharmaceuticals Market 2024-2028


The radiopharmaceuticals market is forecasted to grow by USD 6280.6 mn during 2023-2028, accelerating at a CAGR of 12.17% during the forecast period. The report on the radiopharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising incidence of neurological disorders, growing cancer cases rising investment in the oncology market, and minimal side effects of radiopharmaceuticals.

Technavio's radiopharmaceuticals market is segmented as below:

BySource
  • Cyclotrons
  • Nuclear reactors
ByEnd-user
  • Diagnostics
  • Therapeutics
ByGeography
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the production of cyclotron-based radiopharmaceuticals as one of the prime reasons driving the radiopharmaceuticals market growth during the next few years. Also, the discovery and development of new radiopharmaceuticals and improvement in healthcare infrastructure in emerging economies will lead to sizable demand in the market.

The report on the radiopharmaceuticals market covers the following areas:
  • Radiopharmaceuticals market sizing
  • Radiopharmaceuticals market forecast
  • Radiopharmaceuticals market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading radiopharmaceuticals market vendors that include Bayer AG, Bracco Spa, Cardinal Health Inc., Curium Pharma, Eckert and Ziegler AG, General Electric Co., IBA Radiopharma Solutions, Jubilant Pharmova Ltd., Lantheus Holdings Inc., Mallinckrodt Plc, NorthStar Medical Radioisotopes LLC, Novartis AG, NTP Radioisotopes SOC Ltd., PharmaLogic Holdings Corp., Positron Corp., Radiomedix Inc., Siemens AG, Sinotau Pharmaceuticals, Sotera Health Co., and Telix Pharmaceuticals Ltd. Also, the radiopharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.


1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Source
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Radiopharmaceuticals Market 2018 - 2022
Historic Market Size - Data Table on Global Radiopharmaceuticals Market 2018 - 2022 ($ million)
4.2 Source segment analysis 2018 - 2022
Historic Market Size - Source Segment 2018 - 2022 ($ million)
4.3 End-user segment analysis 2018 - 2022
Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Source
6.1 Market segments
Chart on Source - Market share 2023-2028 (%)
Data Table on Source - Market share 2023-2028 (%)
6.2 Comparison by Source
Chart on Comparison by Source
Data Table on Comparison by Source
6.3 Cyclotrons - Market size and forecast 2023-2028
Chart on Cyclotrons - Market size and forecast 2023-2028 ($ million)
Data Table on Cyclotrons - Market size and forecast 2023-2028 ($ million)
Chart on Cyclotrons - Year-over-year growth 2023-2028 (%)
Data Table on Cyclotrons - Year-over-year growth 2023-2028 (%)
6.4 Nuclear reactors - Market size and forecast 2023-2028
Chart on Nuclear reactors - Market size and forecast 2023-2028 ($ million)
Data Table on Nuclear reactors - Market size and forecast 2023-2028 ($ million)
Chart on Nuclear reactors - Year-over-year growth 2023-2028 (%)
Data Table on Nuclear reactors - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Source
Market opportunity by Source ($ million)
Data Table on Market opportunity by Source ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Chart on End-user - Market share 2023-2028 (%)
Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
7.3 Diagnostics - Market size and forecast 2023-2028
Chart on Diagnostics - Market size and forecast 2023-2028 ($ million)
Data Table on Diagnostics - Market size and forecast 2023-2028 ($ million)
Chart on Diagnostics - Year-over-year growth 2023-2028 (%)
Data Table on Diagnostics - Year-over-year growth 2023-2028 (%)
7.4 Therapeutics - Market size and forecast 2023-2028
Chart on Therapeutics - Market size and forecast 2023-2028 ($ million)
Data Table on Therapeutics - Market size and forecast 2023-2028 ($ million)
Chart on Therapeutics - Year-over-year growth 2023-2028 (%)
Data Table on Therapeutics - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.4 Bracco Spa
Bracco Spa - Overview
Bracco Spa - Product / Service
Bracco Spa - Key offerings
12.5 Cardinal Health Inc.
Cardinal Health Inc. - Overview
Cardinal Health Inc. - Business segments
Cardinal Health Inc. - Key news
Cardinal Health Inc. - Key offerings
Cardinal Health Inc. - Segment focus
12.6 Curium Pharma
Curium Pharma - Overview
Curium Pharma - Product / Service
Curium Pharma - Key offerings
12.7 Eckert and Ziegler AG
Eckert and Ziegler AG - Overview
Eckert and Ziegler AG - Business segments
Eckert and Ziegler AG - Key news
Eckert and Ziegler AG - Key offerings
Eckert and Ziegler AG - Segment focus
12.8 General Electric Co.
General Electric Co. - Overview
General Electric Co. - Business segments
General Electric Co. - Key news
General Electric Co. - Key offerings
General Electric Co. - Segment focus
12.9 IBA Radiopharma Solutions
IBA Radiopharma Solutions - Overview
IBA Radiopharma Solutions - Business segments
IBA Radiopharma Solutions - Key news
IBA Radiopharma Solutions - Key offerings
IBA Radiopharma Solutions - Segment focus
12.10 Jubilant Pharmova Ltd.
Jubilant Pharmova Ltd. - Overview
Jubilant Pharmova Ltd. - Business segments
Jubilant Pharmova Ltd. - Key offerings
Jubilant Pharmova Ltd. - Segment focus
12.11 Lantheus Holdings Inc.
Lantheus Holdings Inc. - Overview
Lantheus Holdings Inc. - Business segments
Lantheus Holdings Inc. - Key offerings
Lantheus Holdings Inc. - Segment focus
12.12 NorthStar Medical Radioisotopes LLC
NorthStar Medical Radioisotopes LLC - Overview
NorthStar Medical Radioisotopes LLC - Product / Service
NorthStar Medical Radioisotopes LLC - Key offerings
12.13 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.14 NTP Radioisotopes SOC Ltd.
NTP Radioisotopes SOC Ltd. - Overview
NTP Radioisotopes SOC Ltd. - Product / Service
NTP Radioisotopes SOC Ltd. - Key offerings
12.15 PharmaLogic Holdings Corp.
PharmaLogic Holdings Corp. - Overview
PharmaLogic Holdings Corp. - Product / Service
PharmaLogic Holdings Corp. - Key offerings
12.16 Siemens AG
Siemens AG - Overview
Siemens AG - Business segments
Siemens AG - Key news
Siemens AG - Key offerings
Siemens AG - Segment focus
12.17 Sotera Health Co.
Sotera Health Co. - Overview
Sotera Health Co. - Business segments
Sotera Health Co. - Key offerings
Sotera Health Co. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Source
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Radiopharmaceuticals Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Source Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Source - Market share 2023-2028 (%)
Exhibits33: Data Table on Source - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Source
Exhibits35: Data Table on Comparison by Source
Exhibits36: Chart on Cyclotrons - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Cyclotrons - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Cyclotrons - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Cyclotrons - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Nuclear reactors - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Nuclear reactors - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Nuclear reactors - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Nuclear reactors - Year-over-year growth 2023-2028 (%)
Exhibits44: Market opportunity by Source ($ million)
Exhibits45: Data Table on Market opportunity by Source ($ million)
Exhibits46: Chart on End-user - Market share 2023-2028 (%)
Exhibits47: Data Table on End-user - Market share 2023-2028 (%)
Exhibits48: Chart on Comparison by End-user
Exhibits49: Data Table on Comparison by End-user
Exhibits50: Chart on Diagnostics - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Diagnostics - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Diagnostics - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Diagnostics - Year-over-year growth 2023-2028 (%)
Exhibits54: Chart on Therapeutics - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Therapeutics - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Therapeutics - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Therapeutics - Year-over-year growth 2023-2028 (%)
Exhibits58: Market opportunity by End-user ($ million)
Exhibits59: Data Table on Market opportunity by End-user ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits103: Impact of drivers and challenges in 2023 and 2028
Exhibits104: Overview on criticality of inputs and factors of differentiation
Exhibits105: Overview on factors of disruption
Exhibits106: Impact of key risks on business
Exhibits107: Companies covered
Exhibits108: Matrix on companies position and classification
Exhibits109: Bayer AG - Overview
Exhibits110: Bayer AG - Business segments
Exhibits111: Bayer AG - Key news
Exhibits112: Bayer AG - Key offerings
Exhibits113: Bayer AG - Segment focus
Exhibits114: Bracco Spa - Overview
Exhibits115: Bracco Spa - Product / Service
Exhibits116: Bracco Spa - Key offerings
Exhibits117: Cardinal Health Inc. - Overview
Exhibits118: Cardinal Health Inc. - Business segments
Exhibits119: Cardinal Health Inc. - Key news
Exhibits120: Cardinal Health Inc. - Key offerings
Exhibits121: Cardinal Health Inc. - Segment focus
Exhibits122: Curium Pharma - Overview
Exhibits123: Curium Pharma - Product / Service
Exhibits124: Curium Pharma - Key offerings
Exhibits125: Eckert and Ziegler AG - Overview
Exhibits126: Eckert and Ziegler AG - Business segments
Exhibits127: Eckert and Ziegler AG - Key news
Exhibits128: Eckert and Ziegler AG - Key offerings
Exhibits129: Eckert and Ziegler AG - Segment focus
Exhibits130: General Electric Co. - Overview
Exhibits131: General Electric Co. - Business segments
Exhibits132: General Electric Co. - Key news
Exhibits133: General Electric Co. - Key offerings
Exhibits134: General Electric Co. - Segment focus
Exhibits135: IBA Radiopharma Solutions - Overview
Exhibits136: IBA Radiopharma Solutions - Business segments
Exhibits137: IBA Radiopharma Solutions - Key news
Exhibits138: IBA Radiopharma Solutions - Key offerings
Exhibits139: IBA Radiopharma Solutions - Segment focus
Exhibits140: Jubilant Pharmova Ltd. - Overview
Exhibits141: Jubilant Pharmova Ltd. - Business segments
Exhibits142: Jubilant Pharmova Ltd. - Key offerings
Exhibits143: Jubilant Pharmova Ltd. - Segment focus
Exhibits144: Lantheus Holdings Inc. - Overview
Exhibits145: Lantheus Holdings Inc. - Business segments
Exhibits146: Lantheus Holdings Inc. - Key offerings
Exhibits147: Lantheus Holdings Inc. - Segment focus
Exhibits148: NorthStar Medical Radioisotopes LLC - Overview
Exhibits149: NorthStar Medical Radioisotopes LLC - Product / Service
Exhibits150: NorthStar Medical Radioisotopes LLC - Key offerings
Exhibits151: Novartis AG - Overview
Exhibits152: Novartis AG - Business segments
Exhibits153: Novartis AG - Key news
Exhibits154: Novartis AG - Key offerings
Exhibits155: Novartis AG - Segment focus
Exhibits156: NTP Radioisotopes SOC Ltd. - Overview
Exhibits157: NTP Radioisotopes SOC Ltd. - Product / Service
Exhibits158: NTP Radioisotopes SOC Ltd. - Key offerings
Exhibits159: PharmaLogic Holdings Corp. - Overview
Exhibits160: PharmaLogic Holdings Corp. - Product / Service
Exhibits161: PharmaLogic Holdings Corp. - Key offerings
Exhibits162: Siemens AG - Overview
Exhibits163: Siemens AG - Business segments
Exhibits164: Siemens AG - Key news
Exhibits165: Siemens AG - Key offerings
Exhibits166: Siemens AG - Segment focus
Exhibits167: Sotera Health Co. - Overview
Exhibits168: Sotera Health Co. - Business segments
Exhibits169: Sotera Health Co. - Key offerings
Exhibits170: Sotera Health Co. - Segment focus
Exhibits171: Inclusions checklist
Exhibits172: Exclusions checklist
Exhibits173: Currency conversion rates for US$
Exhibits174: Research methodology
Exhibits175: Information sources
Exhibits176: Data validation
Exhibits177: Validation techniques employed for market sizing
Exhibits178: Data synthesis
Exhibits179: 360 degree market analysis
Exhibits180: List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings